HedgeSourced 🇺🇸🇨🇭
5.1K posts

HedgeSourced 🇺🇸🇨🇭
@hedgesauce
I love long walks to the bank


this will end in tears btw



Hospital CEOs are currently testifying in front on Congress. @ahahospitals just held its annual meeting, and @_daniel_payne caught this extremely candid quote from Chuck Schumer showing just how much lobbying power hospitals have. statnews.com/2026/04/27/for…




“We've stopped making babies. We've decided that being distracted by a dopamine hit around Candy Crush might be a good way to spend your time. Not if you're a full human," former Sen. Ben Sasse says in an extended interview. cbsn.ws/4cA1Jrp











15% of physicians remain in unaffiliated private practice. In 2010 that number was 75%. The physicians still standing are the ones who held out the longest. They don’t need employment. They need an economic structure that makes independence durable. That is a very large and very underserved market.


This is directly in my lane and I think FebriDx is one of the most important CLIA-waived diagnostics to hit the market in years. For everyone else reading this, here’s what it does. FebriDx is a rapid fingerstick test that measures two biomarkers simultaneously. CRP (C-reactive protein, which rises with bacterial infection) and MxA (myxovirus resistance protein A, which rises specifically with viral infection). One drop of blood. Ten minutes. The combination of those two markers tells the clinician whether the patient’s immune response looks bacterial, viral, or neither. The NPV is the number that matters most in practice. A 97% negative predictive value for bacterial infection means that when FebriDx says it’s not bacterial, it’s right 97% of the time. That’s the number that gives a physician the confidence to say “we’re going to watch this for a few days” instead of writing the antibiotic prescription just in case. The “just in case” prescription is how we got to where we are with antibiotic resistance. The CLIA waiver that just came through last week is the game changer. Before the waiver, FebriDx could only be run in moderate or high-complexity labs. That means a hospital lab. With the waiver, it can now be run in any CLIA-waived setting. Urgent care clinics. Physician offices. Retail health clinics. Long-term care facilities. The test goes from 18,000 eligible sites to 270,000. That’s a 15x expansion in access overnight. For your clinic specifically, this slots in perfectly with the shared decision-making framework we were just discussing. The physician presents the patient with the probability assessment. FebriDx narrows that probability in ten minutes with objective data. The 33% chance antibiotics help becomes either 80% or drops to under 5% depending on what the test shows. The prescription decision gets made with data instead of a guess. Antibiotic stewardship improves. The patient understands why they’re getting or not getting the prescription. Everyone wins. Get it for the clinic. This is point-of-care diagnostics doing exactly what it should do. Putting actionable lab data in the hands of the clinician at the moment the decision is being made instead of three days later when the culture results come back and the Z-pack has already been started. Don’t wait for the diagnosis. Read the label.








More than 400 hospitals across the U.S. are at high risk of closing or cutting services because of the Medicaid cuts in President Trump’s “big, beautiful bill,” according to an analysis from the progressive watchdog group Public Citizen. nbcnews.com/health/health-…






